Little House Capital LLC Biogen Inc. Transaction History

Little House Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 05, 2019	SELL	$217.44 - $243.88 $12,828 - $14,388	-59 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$219.29 - $241.72 $12,938 - $14,261	59 New	59 $14.4 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $21,709 - $23,930	-99 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $21,454 - $33,557	99 New	99 $23,000

1,036

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Little House Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Little House Capital LLC with notifications on news.